Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,517 | -5,236 | N/A | N/A |
| Depreciation Amortization | 12 | 11 | N/A | N/A |
| Accounts payable and accrued liabilities | 819 | 303 | N/A | N/A |
| Other Working Capital | 842 | 302 | N/A | N/A |
| Other Operating Activity | -792 | -300 | 0 | 0 |
| Operating Cash Flow | $-7,636 | $-4,920 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -417 | N/A | N/A | N/A |
| Purchase Of Investment | -5,035 | -4,535 | N/A | N/A |
| Sale Of Investment | 3,673 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,779 | $-4,535 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 10,584 | 0 | 0 | 0 |
| Financing Cash Flow | $10,584 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 9,588 | 19,043 | N/A | N/A |
| End Cash Position | 10,757 | 9,588 | N/A | N/A |
| Net Cash Flow | $1,169 | $-9,455 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,636 | -4,920 | N/A | N/A |
| Capital Expenditure | -417 | N/A | N/A | N/A |
| Free Cash Flow | -8,053 | -4,920 | 0 | 0 |